BioMarin Pharmaceutical Inc (BMRN) stock
BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3091% above fair value
$57.23+0.53 (+0.93%)
Close on Nov 13, 2026Market cap $11.08BP/E 150.6Yield –
BioMarin Pharmaceutical operating margin
Operating margin is operating income as a percentage of revenue.
BioMarin Pharmaceutical's operating margin for the twelve months ending Jun 30, 2026 was 4.4%. For fiscal 2025 it was 12.7%, against 17.0% the year before. The highest annual figure on record is 17.0% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.7% | −4.3 |
| FY2024 | Dec 31, 2024 | 17.0% | +9.3 |
| FY2023 | Dec 31, 2023 | 7.7% | −0.0 |
| FY2022 | Dec 31, 2022 | 7.7% | +12.1 |
| FY2021 | Dec 31, 2021 | -4.5% | −2.1 |
| FY2020 | Dec 31, 2020 | -2.3% | +3.6 |
| FY2019 | Dec 31, 2019 | -5.9% | +2.4 |
| FY2018 | Dec 31, 2018 | -8.3% | −7.2 |
| FY2017 | Dec 31, 2017 | -1.1% | +70.8 |
| FY2016 | Dec 31, 2016 | -71.9% | −59.5 |
| FY2015 | Dec 31, 2015 | -12.4% | −0.0 |
| FY2014 | Dec 31, 2014 | -12.4% | +16.0 |
| FY2013 | Dec 31, 2013 | -28.4% | −6.4 |
| FY2012 | Dec 31, 2012 | -22.0% | −14.3 |
| FY2011 | Dec 31, 2011 | -7.7% | −7.8 |
| FY2010 | Dec 31, 2010 | 0.1% | −4.9 |
| FY2009 | Dec 31, 2009 | 5.1% | −8.3 |
| FY2008 | Dec 31, 2008 | 13.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 11.2% | −22.3 |
| Q1 FY2026 | Mar 31, 2026 | 16.9% | −13.1 |
| Q4 FY2025 | Dec 31, 2025 | -5.1% | −26.7 |
| Q3 FY2025 | Sep 30, 2025 | -6.0% | −21.3 |
| Q2 FY2025 | Jun 30, 2025 | 33.5% | +16.6 |
| Q1 FY2025 | Mar 31, 2025 | 30.0% | +16.4 |
| Q4 FY2024 | Dec 31, 2024 | 21.6% | +17.4 |
| Q3 FY2024 | Sep 30, 2024 | 15.3% | +10.0 |
| Q2 FY2024 | Jun 30, 2024 | 16.9% | +5.9 |
| Q1 FY2024 | Mar 31, 2024 | 13.6% | +3.2 |
| Q4 FY2023 | Dec 31, 2023 | 4.2% | +6.7 |
| Q3 FY2023 | Sep 30, 2023 | 5.3% | +5.7 |
| Q2 FY2023 | Jun 30, 2023 | 11.0% | +3.7 |
| Q1 FY2023 | Mar 31, 2023 | 10.5% | −16.0 |
| Q4 FY2022 | Dec 31, 2022 | -2.4% | +12.2 |
| Q3 FY2022 | Sep 30, 2022 | -0.5% | +12.5 |
| Q2 FY2022 | Jun 30, 2022 | 7.3% | +5.0 |
| Q1 FY2022 | Mar 31, 2022 | 26.4% | +21.3 |
| Q4 FY2021 | Dec 31, 2021 | -14.6% | −3.3 |
| Q3 FY2021 | Sep 30, 2021 | -13.0% | −1.3 |
| Q2 FY2021 | Jun 30, 2021 | 2.3% | +11.9 |
| Q1 FY2021 | Mar 31, 2021 | 5.2% | −15.7 |
| Q4 FY2020 | Dec 31, 2020 | -11.4% | −9.4 |
| Q3 FY2020 | Sep 30, 2020 | -11.7% | −12.6 |
| Q2 FY2020 | Jun 30, 2020 | -9.5% | +1.1 |
| Q1 FY2020 | Mar 31, 2020 | 20.9% | +34.4 |
| Q4 FY2019 | Dec 31, 2019 | -2.0% | +8.8 |
| Q3 FY2019 | Sep 30, 2019 | 0.9% | +4.9 |
| Q2 FY2019 | Jun 30, 2019 | -10.7% | −3.9 |
| Q1 FY2019 | Mar 31, 2019 | -13.5% | −1.6 |
| Q4 FY2018 | Dec 31, 2018 | -10.8% | −27.0 |
| Q3 FY2018 | Sep 30, 2018 | -4.0% | +0.1 |
| Q2 FY2018 | Jun 30, 2018 | -6.8% | +5.5 |
| Q1 FY2018 | Mar 31, 2018 | -11.9% | −5.2 |
| Q4 FY2017 | Dec 31, 2017 | 16.2% | +46.1 |
| Q3 FY2017 | Sep 30, 2017 | -4.1% | +17.4 |
| Q2 FY2017 | Jun 30, 2017 | -12.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -6.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -29.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -21.5% | – |
See a number that looks wrong?